학술논문

Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
Document Type
Article
Source
In The Lancet Rheumatology January 2022 4(1):e42-e52
Subject
Primary Research
Articles
Language
ISSN
2665-9913